HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma
HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma
About this item
Full title
Author / Creator
Dong, Yan , Cai, Ying , Liu, Bo , Jiao, Xiang , Li, Zhong-tai , Guo, Da-yong , Li, Xin-wei , Wang, Yong-jun and Yang, Deng-ke
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
To investigate the clinical relevance and functional role of HOXA13 in prostate cancer Methods: PCR, western blot and immunohistochemistry were performed to determine the expression. Kaplan-Meier and Cox regression survival analyses investigated the clinical relevance. Cell viability, flow cytometry and transwell assays were used to determine the f...
Alternative Titles
Full title
HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2275875211
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2275875211
Other Identifiers
ISSN
1479-6694
E-ISSN
1744-8301
DOI
10.2217/fon-2016-0522
